Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta.

Expression of AP-2 transcription factors has been detected previously in embryonic renal tissues. We show here that AP-2beta -/- mice complete embryonic development and die at postnatal days 1 and 2 because of polycystic kidney disease. Analyses of kidney development revealed that induction of epithelial conversion, mesenchyme condensation, and further glomerular and tubular differentiation occur normally in AP-2beta-deficient mice. At the end of embryonic development expression of bcl-X(L), bcl-w, and bcl-2 is down-regulated in parallel to massive apoptotic death of collecting duct and distal tubular epithelia. Addressing the molecular mechanism we show that transfection of AP-2 into cell lines in vitro strongly suppresses c-myc-induced apoptosis pointing to a function of AP-2 in programming cell survival during embryogenesis. The position of the human AP-2beta gene was identified at chromosome 6p12-p21.1, within a region that has been mapped for autosomal recessive polycystic kidney disease (ARPKD). Sequence analyses of ARPKD patients and linkage analyses using intragenic polymorphic markers indicate that the AP-2beta gene is located in close proximity to but distinct from the ARPKD gene.

[1]  E. Avner,et al.  An integrated genetic and physical map of the autosomal recessive polycystic kidney disease region. , 1997, Genomics.

[2]  J. Rüschoff,et al.  Comparative analysis of AP‐2α and AP‐2β gene expression during murine embryogenesis , 1997 .

[3]  F. Hofmann,et al.  Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II , 1996, Science.

[4]  D. Sheer,et al.  Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. , 1996, Genomics.

[5]  P. Chambon,et al.  AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. , 1996, Experimental cell research.

[6]  A. McMahon,et al.  Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2 , 1996, Nature.

[7]  R. Jaenisch,et al.  Transcription factor AP-2 essential for cranial closure and craniofacial development , 1996, Nature.

[8]  K. Zerres,et al.  Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender , 1996, Acta paediatrica.

[9]  P. Chambon,et al.  AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis , 1996, Mechanisms of Development.

[10]  R. Schüle,et al.  Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. , 1995, Development.

[11]  S Gaubatz,et al.  Transcriptional activation by Myc is under negative control by the transcription factor AP‐2. , 1995, The EMBO journal.

[12]  T. Williams,et al.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Korsmeyer,et al.  Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. , 1995, The American journal of physiology.

[14]  C. Thompson,et al.  bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. , 1994, Development.

[15]  B. Wirth,et al.  Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21–cen , 1994, Nature Genetics.

[16]  M. Sarkiss,et al.  N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. , 1994, Genes & development.

[17]  S. Korsmeyer,et al.  Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.

[18]  M. Raff,et al.  Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. , 1993, Development.

[19]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[20]  D. Green,et al.  Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.

[21]  V. D’Agati,et al.  C-myc as an inducer of polycystic kidney disease in transgenic mice. , 1991, Kidney international.

[22]  R. Tjian,et al.  Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. , 1991, Genes & development.

[23]  R. Tjian,et al.  Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. , 1991, Science.

[24]  R. Tjian,et al.  Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. , 1991, Genes & development.

[25]  G Hermanson,et al.  High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. , 1990, Science.

[26]  R. Tjian,et al.  Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. , 1988, Genes & development.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .